商务合作
动脉网APP
可切换为仅中文
Hamilton Spence Is Among Few Neonatologists Awarded This Specialized Designation
汉密尔顿·斯宾塞是少数获得这一特殊称号的新生儿科医生之一。
DUARTE, Calif.
杜阿尔特,加利福尼亚州
,
,
March 18, 2025
2025年3月18日
/PRNewswire/ -- Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, announced today that
/PRNewswire/ -- Prolacta Bioscience,全球领先的专注于为重症和早产婴儿提供100%人乳营养产品的医院供应商,今天宣布
Erin Hamilton Spence
艾琳·汉密尔顿·斯宾塞
, MD, IBCLC, FAAP, FABM, and director of clinical education and professional development at Prolacta, earned board certification in breastfeeding and lactation medicine. This specialized designation from the
,医学博士,国际认证哺乳顾问,美国儿科学会会员,母乳喂养医学学会会员,Prolacta临床教育与专业发展总监,获得了母乳喂养和泌乳医学的委员会认证。这一专业称号来自
North American Board of Breastfeeding and Lactation Medicine
北美母乳喂养与泌乳医学委员会
(NABBLM) is held by fewer than 100 physicians in
(NABBLM) 仅由不到100名医生持有
the United States
美国
and
和
Canada
加拿大
.
。
Continue Reading
继续阅读
Dr. Erin Hamilton Spence
艾琳·汉密尔顿·斯宾塞博士
The board certification enhances Hamilton Spence's ability to advocate for the critical benefits of breast milk and support Prolacta's donor community. This prestigious designation recognizes physicians who have met rigorous education, licensure, and practice requirements in breastfeeding and lactation medicine.
董事会的认证增强了汉密尔顿·斯宾塞为母乳的重要益处进行倡导和支持Prolacta捐赠者社区的能力。这一声望卓著的称号认可了那些在母乳喂养和泌乳医学方面满足严格教育、许可和实践要求的医生。
While often associated with direct lactation care, Hamilton Spence applies her expertise to overseeing Prolacta's donor risk assessment protocols, one of many steps toward ensuring both quality and safety in Prolacta's human milk-based nutritional products..
虽然汉密尔顿·斯宾塞常与直接的哺乳护理相关联,但她将自己的专业知识应用于监督Prolacta的捐赠者风险评估协议,这是确保Prolacta基于人类乳汁的营养产品在质量和安全方面的众多步骤之一。
These protocols prioritize the health of donors and their infants in three important ways:
这些协议以三种重要方式优先考虑捐赠者及其婴儿的健康:
Aligning with global health recommendations that donors' infants are fed exclusively human milk up to 6 months of age through direct communication from their healthcare providers and the donors themselves.
与全球健康建议保持一致,即通过医疗保健提供者和捐赠者本人的直接沟通,捐赠者的婴儿在6个月大之前只喂养人乳。
Empowering donors to adapt their milk donations through screening protocols that encourage them to voluntarily separate any milk that may have been exposed to illness or medications, ensuring that only eligible milk is used in production while recognizing and valuing the effort involved in producing an excess supply..
赋予捐赠者通过筛查协议来调整他们的母乳捐赠,鼓励他们自愿分离任何可能接触过疾病或药物的母乳,确保只有合格的母乳被用于生产,同时认可并重视生产多余母乳所付出的努力。
Providing personalized support throughout the donation process, including guidance on safe milk handling, storage, and delivery, to help donors maintain the highest quality standards.
在整个捐赠过程中提供个性化支持,包括安全的牛奶处理、储存和运送指导,以帮助捐赠者保持最高质量标准。
Prolacta sets the industry standard by voluntarily developing and implementing rigorous safety measures to protect the fragile infants who rely on its human milk-based nutritional fortifiers.
Prolacta 通过自愿开发和实施严格的安全措施,为依赖其基于人乳的营养强化剂的脆弱婴儿提供保护,从而树立了行业标准。
'Prolacta's donors play a vital role in helping the most vulnerable infants thrive through the power of human milk-based nutrition,' said Hamilton Spence. 'These extraordinary donors go beyond nourishing their own babies — they devote time, energy, and care to pump, store, and ship their surplus breast milk, providing life-changing support for medically fragile, preterm and term infants who depend on this critical resource.'.
“Prolacta的捐赠者在通过基于母乳的营养帮助最脆弱的婴儿茁壮成长方面发挥着至关重要的作用,”汉密尔顿·斯宾塞说道。“这些非凡的捐赠者所做的不仅仅是滋养自己的孩子——他们投入时间、精力和关怀来泵取、储存和运送他们多余的母乳,为依赖这一关键资源的医学上脆弱的早产儿和足月婴儿提供改变生命的帮助。”
Hamilton Spence is an experienced neonatologist with a demonstrated history of clinical leadership in some of the country's top neonatal intensive care units (NICUs), including
汉密尔顿·斯彭斯是一位经验丰富的新生儿科医生,曾在该国一些顶级的新生儿重症监护室(NICUs)中展现出临床领导能力,包括
Cook Children's Medical Center
库克儿童医疗中心
and
和
Baylor Scott
贝勒·斯科特
& White Health-Andrews Women's Hospital
& 白人健康-安德鲁斯女子医院
. As one of Prolacta's medical experts, she educates neonatologists and hospital care teams about improving premature infant outcomes through an Exclusive Human Milk Diet (EHMD) for vulnerable infants.
作为Prolacta的医学专家之一,她向新生儿科医生和医院护理团队宣传通过为脆弱的婴儿提供纯母乳饮食(EHMD)来改善早产儿预后的方法。
'Dr. Hamilton Spence's expertise as a neonatologist, lactation consultant, and human milk researcher gives her unique insight into breast milk's vital role in infant health,' said
“汉密尔顿·斯宾塞博士作为新生儿科医生、哺乳顾问和人乳研究员的专业知识,使她对母乳在婴儿健康中的重要作用有着独特的见解,”
Scott Elster
斯科特·埃尔斯特
, CEO of Prolacta
,Prolacta首席执行官
. 'This new breastfeeding and lactation certification further demonstrates her dedication to supporting families, particularly those with premature and critically ill newborns.'
“这个新的母乳喂养和泌乳认证进一步证明了她对支持家庭的奉献精神,特别是那些有早产儿和重病新生儿的家庭。”
About Prolacta Bioscience
关于Prolacta生物科学
Prolacta Bioscience
普罗拉克塔生物科学
®
®
is a global life sciences company dedicated to Advancing the Science of Human Milk
是一家致力于推进人类母乳科学的全球生命科学公司
®
®
to improve health outcomes for critically ill and premature infants. More than 100,000 extremely premature infants worldwide
改善危重病和早产婴儿的健康状况。 全球超过10万名极度早产的婴儿
1
1
have benefited from Prolacta's human milk-based products, which have been evaluated in more than 30 peer-reviewed clinical studies. Operating the world's first pharmaceutical-grade human milk processing facilities, Prolacta maintains the industry's strictest quality and safety standards, with over 20 validated tests for screening and testing human milk.
已受益于Prolacta的人乳基产品,这些产品已在30多项同行评审的临床研究中得到评估。Prolacta运营着全球首个药用级人乳处理设施,保持着行业内最严格的质量和安全标准,并拥有20多项经过验证的检测方法用于筛查和测试人乳。
Prolacta's manufacturing process uses vat pasteurization to ensure pathogen inactivation while protecting nutritional composition and bioactivity. Learn more at.
Prolacta的生产过程使用缸式巴氏杀菌法,在确保病原体灭活的同时保护营养成分和生物活性。了解更多,请访问。
www.prolacta.com
www.prolacta.com
, on
,打开
X
X
,
,
,
,
, and
,以及
领英
.
。
Media Contact:
媒体联系人:
Loren Kosmont
洛伦·科斯蒙特
Lkosmont@prolacta.com
Lkosmont@prolacta.com
310-721-9444
310-721-9444
Reference
参考文献
Data on file; estimated number of premature infants fed Prolacta's products from
数据存档;估计喂养过Prolacta产品的早产儿数量
January 2007
2007年1月
to
至
August 2023
2023年8月
.
。
SOURCE Prolacta Bioscience
来源:Prolacta Bioscience
WANT YOUR COMPANY'S NEWS
想要你公司的新闻吗
FEATURED ON PRNEWSWIRE.COM?
刊登在PRNEWSWIRE.COM上?
440k+
44万+
Newsrooms &
新闻编辑室 &
Influencers
影响者
9k+
9k+
Digital Media
数字媒体
Outlets
插座
270k+
27万+
Journalists
记者
Opted In
已选择加入
GET STARTED
开始使用